Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | WDR5 | P61964 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8579155 | 0.79 | HSD17B10 (0.37) | MYCWDR5ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL22577131 | 0.78 | RECQL (0.34) | ALDH1A1KDM4ESMN1; SMN2L3MBTL1NPSR1 | |
| SCHEMBL22577269 | 0.76 | RECQL (0.33) | ALDH1A1KDM4ESMN1; SMN2L3MBTL1NPSR1 | |
| SCHEMBL10350066 | 0.72 | — | — | |
| SCHEMBL8555731 | 0.72 | — | — | |
| SCHEMBL5154943 | 0.72 | — | — | |
| SCHEMBL4305992 | 0.72 | — | — | |
| SCHEMBL5537146 | 0.70 | KDM4E (0.34) | ALDH1A1KDM4ESMN1; SMN2HPGDCYP3A4 | |
| SCHEMBL17951012 | 0.70 | MYC (0.64) | MYCWDR5ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL9479129 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5811554-A | REACTING AN IMINOETHER WITH A HALOGENATING AGENT AND THIOUREA; USED IN MAKING NOVEL AZO DYES | AGFA-GEVAERT, N.V. (BE) | 1998-09-22 | — | — | US | claimed |
| EP-0687674-A1 | Preparation of 2-amino-4-alkoxythiazoles being negatively substituted in the 5 position | AGFA-GEVAERT N.V. (BE) | 1995-12-20 | — | — | EP | claimed |
| JP-8003151-A | — | — | None | — | — | JP | disclosed |
| US-20200337311-A1 | FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2020-10-29 | — | — | US | disclosed |
| US-20200337311-A1 | FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2020-10-29 | — | — | US | disclosed |
| EP-3728204-A1 | FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | PI Industries Ltd. (IN) | 2020-10-28 | — | — | EP | disclosed |
| CN-111670180-A | Fluoroalkenyl compounds, process for their preparation and their use | PI工业有限公司 | 2020-09-15 | — | — | CN | disclosed |
| US-5811554-A | REACTING AN IMINOETHER WITH A HALOGENATING AGENT AND THIOUREA; USED IN MAKING NOVEL AZO DYES | AGFA-GEVAERT, N.V. (BE) | 1998-09-22 | — | — | US | disclosed |
| JP-H083151-A | PRODUCTION OF 2-AMONO-4-ALKOXYTHIAZOLE NEGATIVELY SUBSTITUTED AT 5-POSITION | AGFA GEVAERT NV | 1996-01-09 | — | — | JP | disclosed |
| EP-0687674-A1 | Preparation of 2-amino-4-alkoxythiazoles being negatively substituted in the 5 position | AGFA-GEVAERT N.V. (BE) | 1995-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200337311-A1 | FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | PFAS, C1S, AFF1 | MYC 2232/4885WDR5 3152/4885ALDH1A1 1593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.